THINQ Pharma CRO Ltd

Main products: 2-Nitrobenzenesulfenyl chloride,1,3-Dichloroisoquinoline

Current Location: Manufacturer >> THINQ Pharma CRO Ltd
COMPONY INTRODUCTION
Enterprise Certification: Learn more about us >
Pharma-CRO Limited undertakes contract formulation development of Generic (Prescription & OTC), NCEs and proof of concept products (505(b)2 & Hybrid) of various dosage forms, aided by state-of-the-art technology and equipment. Formulation designs include: To develop proof of concept and create position by proactively patenting technology; Ethical Products; Veterinary Products; Efficient Project Management; To develop non-infringing (NIF) strategies, patent drafting, filing and coordinating with IP agents and attorneys.Scope of Work: Literature Information & Primary Patent Status Evaluation landscaping and development strategy; Prototype Formulation Development in compliance with latest regulatory guidance such as ICH Q8 QbD; Packaging Development; Scale-up of selected Prototype Formulation; Process Optimization through QbD (ICH Q8); Process Validation; Manufacture of Exhibit/Bio-batch; Bioequivalence Study; Product Development Report; Documentation in CTD Format; Technology...

Business Scope:

We are specialty chemicals and intermediates manufacturers, also can do CRO

Type of Enterprise:

Manufacturer

Location:

India 

Founded Date:

2020-03-01

Contact Supplier
THINQ Pharma CRO Ltd
Country: India
Tel: +91-8879460113
Mobile: +91-8879460113
E-mail: enquiry@thinqcro.com
WhatsApp: Chat Now!
Skype: Chat Now!